Insulin-induced epidermal growth factor activation in vascular smooth muscle cells is ADAM-dependent

Medicine & Life Sciences

• Disintegrins 100%
• Metalloproteases 81%
• Vascular Smooth Muscle 74%
• Epidermal Growth Factor 74%
• ErbB Receptors 72%
• Smooth Muscle Myocytes 67%
• Insulin 51%
• 2-aminoethylamide N-((2-(hydroxyaminocarbonyl)methyl)-4-methylpentanoyl)-3-(2'-naphthyl)alanylalanine 33%
• Heparin 26%
• Receptor Cross-Talk 18%
• RTKI cpd 17%
• Phosphorylation 16%
• Antifibrinolytic Agents 14%
• Receptor Protein-Tyrosine Kinases 12%
• G-Protein-Coupled Receptors 11%
• Transcriptional Activation 10%
• CRM197 (non-toxic variant of diphtheria toxin) 9%
• N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide 9%
• Aminocaproic Acid 8%
• Aprotinin 7%
• Tumor Necrosis Factor Inhibitors 7%
• Fibrinolysin 6%
• Antibodies 6%
• Protease Inhibitors 6%
• Matrix Metalloproteinases 5%
• Metabolic Syndrome 5%
• Signal Transduction 4%
• Ligands 4%
• In Vitro Techniques 2%